Exact Mass: 474.23006440000006
Exact Mass Matches: 474.23006440000006
Found 443 metabolites which its exact mass value is equals to given mass value 474.23006440000006
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Methylprednisolone succinate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D020011 - Protective Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Austalide B
Austalide B is a mycotoxin of. of the food storage mould Aspergillus ustu
Danusertib
Darexaban
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent
Macimorelin
Methylprednisolone hemisuccinate
Saterinone
Methylprednisolone 17-hemisuccinate
3-beta-D-glucopyranosyl-6beta-hydroxyethinylestradiol
16-Ac-(3beta,5beta,14beta,15beta,16beta)-14,15-Epoxy-3,5,16,19-tetrahydroxybufa-20,22-dienolide
3-Ac-(3beta,5beta,11alpha,14beta)-3,5,11,14-Tetrahydroxy-12-oxobufa-20,22-dienolide
14(17)-dehydrocaesalmin F|14(17)-dehydrocaesalpin F
(1alpha,2alpha,9beta)-1,14-bis(acetyloxy)-9-(benzoyloxy)-2-hydroxydihydro-beta-agarofuran|rel-(3R,5S,5aR,6R,7S,9R,9aS)-5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-5,6,7-triol 6-acetate 5-benzoate
(1alpha,2alpha,9beta)-2,14-bis(acetyloxy)-9-(benzoyloxy)-1-hydroxydihydro-beta-agarofuran|rel-(3R,5S,5aS,6R,7S,9R,9aS)-5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-5,6,7-triol 7-acetate 5-benzoate
bersaldegenin 1-acetate|bersaldegenin-1-acetate|Bersaldegenin-1-O-acetate
3-Ac-(3beta,5beta,12beta,14beta)-3,5,12,14-Tetrahydroxy-11-oxobufa-20,22-dienolide
3alpha,17,19-triacetoxyspongia-13(16),14-dien-2-one|3alpha,17,19-Triacetoxyspongin-13(16),14-dien-2-on
9beta-Benzoyloxy-1alpha,6beta-diacetoxy-15-hydroxydihydro-beta-agarofuran
Tri-Ac(6alpha)-2alpha-2,11,12-Trihydroxy-6,7-seco-8,11,13-abietatriene-6,7-dial 11,6-hemiacetal
(1S,4R,5S,6R,7S,8S,9R,10S)-1,8-diacetoxy-9-benzoyloxy-6-hydroxy-dihydro-beta-agarofuran
(1alpha,2alpha,8beta,9beta)-1,8-bis(acetyloxy)-9-(benzoyloxy)-2-hydroxy-beta-dihydroagarofuran
4-O-Methyisocryptochlorophaeic acid|4-O-methylisocryptochlorophaeic acid
1alpha-benzoyloxy-6beta,9beta-diacetoxy-4beta-hydroxydihydro-beta-agarofuran
(1S,4R,5S,6R,7R,8R,9S,10S)-6,8-diacetoxy-9-benzoyloxy-1-hydroxydihydro-beta-agarofuran
3,4,5-trimethoxy-benzoic acid 9-hydroxy-11-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester|Catalaudesmin
3alpha-angeloyloxy-4beta,10beta-dihydroxy-8beta,17,15,16-bis-epoxy-cis-clerodane-13(16),14-dien-20,12-olide
Ile Val Glu Asp
Ile Asp Val Glu
C26H34O8_(1R,2R,4S,16R,17R,20S)-2-Hydroxy-13,20-dimethoxy-4,7,17,22,22-pentamethyl-5,10,21,23-tetraoxahexacyclo[18.2.1.0~1,17~.0~4,16~.0~6,14~.0~8,12~]tricosa-6(14),7,12-trien-11-one
Ala Ala Gln Trp
Ala Ala Trp Gln
Ala Phe His Thr
Ala Phe Thr His
Ala His Phe Thr
Ala His Thr Phe
Ala Gln Ala Trp
Ala Gln Trp Ala
Ala Thr Phe His
Ala Thr His Phe
Ala Trp Ala Gln
Ala Trp Gln Ala
Cys Lys Pro Gln
C19H34N6O6S (474.22604240000004)
Cys Lys Gln Pro
C19H34N6O6S (474.22604240000004)
Cys Pro Lys Gln
C19H34N6O6S (474.22604240000004)
Cys Pro Gln Lys
C19H34N6O6S (474.22604240000004)
Cys Gln Lys Pro
C19H34N6O6S (474.22604240000004)
Cys Gln Pro Lys
C19H34N6O6S (474.22604240000004)
Asp Asp Ile Ile
Asp Asp Ile Leu
Asp Asp Leu Ile
Asp Asp Leu Leu
Asp Glu Ile Val
Asp Glu Leu Val
Asp Glu Val Ile
Asp Glu Val Leu
Asp Ile Asp Ile
Asp Ile Asp Leu
Asp Ile Glu Val
Asp Ile Ile Asp
Asp Ile Leu Asp
Asp Ile Val Glu
Asp Leu Asp Ile
Asp Leu Asp Leu
Asp Leu Glu Val
Asp Leu Ile Asp
Asp Leu Leu Asp
Asp Leu Val Glu
Asp Val Glu Ile
Asp Val Glu Leu
Asp Val Ile Glu
Asp Val Leu Glu
Glu Asp Ile Val
Glu Asp Leu Val
Glu Asp Val Ile
Glu Asp Val Leu
Glu Glu Val Val
Glu Ile Asp Val
Glu Ile Val Asp
Glu Leu Asp Val
Glu Leu Val Asp
Glu Val Asp Ile
Glu Val Asp Leu
Glu Val Glu Val
Glu Val Ile Asp
Glu Val Leu Asp
Glu Val Val Glu
Phe Ala His Thr
Phe Ala Thr His
Phe His Ala Thr
Phe His Thr Ala
Phe Thr Ala His
Phe Thr His Ala
Gly Gly Arg Trp
Gly Gly Trp Arg
Gly His Val Tyr
Gly His Tyr Val
Gly Asn Val Trp
Gly Asn Trp Val
Gly Arg Gly Trp
Gly Arg Trp Gly
Gly Val His Tyr
Gly Val Asn Trp
Gly Val Trp Asn
Gly Val Tyr His
Gly Trp Gly Arg
Gly Trp Asn Val
Gly Trp Arg Gly
Gly Trp Val Asn
Gly Tyr His Val
Gly Tyr Val His
His Ala Phe Thr
His Ala Thr Phe
His Phe Ala Thr
His Phe Thr Ala
His Gly Val Tyr
His Gly Tyr Val
His Thr Ala Phe
His Thr Phe Ala
His Val Gly Tyr
His Val Tyr Gly
His Tyr Gly Val
His Tyr Val Gly
Ile Asp Asp Ile
Ile Asp Asp Leu
Ile Asp Glu Val
Ile Asp Ile Asp
Ile Asp Leu Asp
Ile Glu Asp Val
Ile Glu Val Asp
Ile Ile Asp Asp
Ile Leu Asp Asp
Ile Val Asp Glu
Lys Cys Pro Gln
C19H34N6O6S (474.22604240000004)
Lys Cys Gln Pro
C19H34N6O6S (474.22604240000004)
Lys Pro Cys Gln
C19H34N6O6S (474.22604240000004)
Lys Pro Gln Cys
C19H34N6O6S (474.22604240000004)
Lys Gln Cys Pro
C19H34N6O6S (474.22604240000004)
Lys Gln Pro Cys
C19H34N6O6S (474.22604240000004)
Leu Asp Asp Ile
Leu Asp Asp Leu
Leu Asp Glu Val
Leu Asp Ile Asp
Leu Asp Leu Asp
Leu Asp Val Glu
Leu Glu Asp Val
Leu Glu Val Asp
Leu Ile Asp Asp
Leu Leu Asp Asp
Leu Val Asp Glu
Leu Val Glu Asp
Asn Gly Val Trp
Asn Gly Trp Val
Asn Val Gly Trp
Asn Val Trp Gly
Asn Trp Gly Val
Asn Trp Val Gly
Pro Cys Lys Gln
C19H34N6O6S (474.22604240000004)
Pro Cys Gln Lys
C19H34N6O6S (474.22604240000004)
Pro Lys Cys Gln
C19H34N6O6S (474.22604240000004)
Pro Lys Gln Cys
C19H34N6O6S (474.22604240000004)
Pro Gln Cys Lys
C19H34N6O6S (474.22604240000004)
Pro Gln Lys Cys
C19H34N6O6S (474.22604240000004)
Gln Ala Ala Trp
Gln Ala Trp Ala
Gln Cys Lys Pro
C19H34N6O6S (474.22604240000004)
Gln Cys Pro Lys
C19H34N6O6S (474.22604240000004)
Gln Lys Cys Pro
C19H34N6O6S (474.22604240000004)
Gln Lys Pro Cys
C19H34N6O6S (474.22604240000004)
Gln Pro Cys Lys
C19H34N6O6S (474.22604240000004)
Gln Pro Lys Cys
C19H34N6O6S (474.22604240000004)
Gln Trp Ala Ala
Arg Gly Gly Trp
Arg Gly Trp Gly
Arg Trp Gly Gly
Thr Ala Phe His
Thr Ala His Phe
Thr Phe Ala His
Thr Phe His Ala
Thr His Ala Phe
Thr His Phe Ala
Val Asp Glu Ile
Val Asp Glu Leu
Val Asp Ile Glu
Val Asp Leu Glu
Val Glu Asp Ile
Val Glu Asp Leu
Val Glu Glu Val
Val Glu Ile Asp
Val Glu Leu Asp
Val Glu Val Glu
Val Gly His Tyr
Val Gly Asn Trp
Val Gly Trp Asn
Val Gly Tyr His
Val His Gly Tyr
Val His Tyr Gly
Val Ile Asp Glu
Val Ile Glu Asp
Val Leu Asp Glu
Val Leu Glu Asp
Val Asn Gly Trp
Val Asn Trp Gly
Val Val Glu Glu
Val Trp Gly Asn
Val Trp Asn Gly
Val Tyr Gly His
Val Tyr His Gly
Trp Ala Ala Gln
Trp Ala Gln Ala
Trp Gly Gly Arg
Trp Gly Asn Val
Trp Gly Arg Gly
Trp Gly Val Asn
Trp Asn Gly Val
Trp Asn Val Gly
Trp Gln Ala Ala
Trp Arg Gly Gly
Trp Val Gly Asn
Trp Val Asn Gly
Tyr Gly His Val
Tyr Gly Val His
Tyr His Gly Val
Tyr His Val Gly
Tyr Val Gly His
Tyr Val His Gly
Austalide B
1,1-Bis(di-tert-butylphosphino)ferrocene
C26H44FeP2 (474.22674739999997)
N-(4-CHLORO-3-NITROPHENYL)-4-(2,4-DI-TERT-PENTYLPHENOXY)BUTANAMIDE
C26H35ClN2O4 (474.22852200000005)
A-740003
A-740003 is a potent, selective and competitive P2X7 receptor antagonist with IC50 values are 18 and 40 nM for rat and human P2X7 receptors, respectively.
N-{5-[Methoxy(phenyl)acetyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyra zol-3-yl}-4-(4-methyl-1-piperazinyl)benzamide
danusertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
XMD8-92
XMD8-92 is a potent ERK5 (BMK1)/BRD4 inhibitor with Kds of 80 and 190 nM, respectively. XMD8-92 inhibits DCAMKL2, PLK4 and TNK1 with Kds of 190, 600 and 890 nM, respectively. Anti-cancer activity[1][2].
1,4-bis[(2-ethyl-6-methylphenyl)amino]anthraquinone
Macimorelin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76358 - Growth Hormone-Releasing Hormone Analogue V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CD - Tests for pituitary function
4-[[11-hydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid
(3S)-1,2,3,6,7,7a,10,14,14abeta,14b-Decahydro-6alpha-hydroxy-3alpha,13-dimethoxy-5,5,7abeta,9,14balpha-pentamethyl-12H-3beta,5abeta-epoxy-5H-furo[3,4-i]oxepino[4,3-a]xanthen-12-one
6-methoxy-3-[[[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl-(2-phenylethyl)amino]methyl]-1H-quinolin-2-one
1-[2-(diethylamino)ethyl]-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]-3-(2-oxolanylmethyl)thiourea
C24H34N4O4S (474.23006440000006)
Methyl 3-anilino-2-(1,7-dimethylindol-3-yl)-2,3-diphenylpropanoate
(4-fluorophenyl)-[(8R,9S,10R)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
C29H31FN2O3 (474.23185879999994)
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-[(2-methoxyphenyl)methyl]-6-oxo-N-(2-pyridin-4-ylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-[(2-methoxyphenyl)methyl]-6-oxo-N-(2-pyridin-4-ylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C24H34N4O4S (474.23006440000006)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C24H34N4O4S (474.23006440000006)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C24H34N4O4S (474.23006440000006)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C24H34N4O4S (474.23006440000006)
(4-fluorophenyl)-[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
C29H31FN2O3 (474.23185879999994)
(4-fluorophenyl)-[(8S,9S,10S)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
C29H31FN2O3 (474.23185879999994)
(4-fluorophenyl)-[(8S,9R,10S)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
C29H31FN2O3 (474.23185879999994)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C24H34N4O4S (474.23006440000006)
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-thiazolylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C24H34N4O4S (474.23006440000006)
(4-fluorophenyl)-[(8S,9S,10R)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
C29H31FN2O3 (474.23185879999994)
(4-fluorophenyl)-[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
C29H31FN2O3 (474.23185879999994)
(4-fluorophenyl)-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
C29H31FN2O3 (474.23185879999994)
(4-fluorophenyl)-[(8R,9R,10R)-10-(hydroxymethyl)-9-[4-(3-methoxyphenyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
C29H31FN2O3 (474.23185879999994)
(1-acetyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
BisMePA(18:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
16-hydroxy-4-methoxy-2,6,14,17-tetramethyl-14-(5-oxooxolane-3-carbonyl)-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-ene-3,11-dione
methyl (2s,4as,4bs,5s,6as,10as,10bs,12as)-5-hydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,6,8-tetraoxo-hexahydro-4ah-phenanthro[1,2-c]pyran-2-carboxylate
4,8-bis(acetyloxy)-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-12-yl acetate
1,2-bis(acetyloxy)-4a-hydroxy-4,4,11b-trimethyl-7-methylidene-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-3-yl acetate
1-methoxy-3-methyl-9-[(1s)-3,3,5-trimethyl-1h,2h,11h-pyrano[3,2-a]carbazol-1-yl]carbazole
5-[(1s,4r,5s,8r,9r,11r,12s,13r,14r,16r,18s)-5,11-dihydroxy-13-(hydroxymethyl)-9,16-dimethyl-15,17,20-trioxahexacyclo[14.3.1.1¹⁴,¹⁸.0¹,¹³.0⁴,¹².0⁵,⁹]henicosan-8-yl]pyran-2-one
(1r,2r,4s,16r,17r,20s)-2-hydroxy-13,20-dimethoxy-4,7,17,22,22-pentamethyl-5,10,21,23-tetraoxahexacyclo[18.2.1.0¹,¹⁷.0⁴,¹⁶.0⁶,¹⁴.0⁸,¹²]tricosa-6,8(12),13-trien-11-one
methyl (3r,4ar,4bs,5s,6as,10as,10bs,12ar)-5-hydroxy-3,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,6,8-tetraoxo-hexahydro-3h-phenanthro[2,1-c]pyran-4a-carboxylate
5,12-bis(acetyloxy)-6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
methyl (2s,4ar,4bs,5s,6ar,10as,10bs,12as)-5-hydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,6,8-tetraoxo-hexahydro-4ah-phenanthro[1,2-c]pyran-2-carboxylate
(8r,9r,10r)-3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-8-yl acetate
(1r,3as,3br,5as,7s,9r,9ar,9bs,11ar)-9a-formyl-3a,5a,7-trihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate
(8s,9s,10r)-3,4,8,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-5-yl acetate
(1s,7s,8z,11r,12r,13r,14s)-12,14-bis(acetyloxy)-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-3,8,16-trien-11-yl acetate
(1s,2s,6s,7s,9r,13r,14r,16r,17s)-16-hydroxy-4-methoxy-2,6,14,17-tetramethyl-14-[(3s)-5-oxooxolane-3-carbonyl]-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-ene-3,11-dione
[(1r,4r,5s,10r,11r,13r)-11-(acetyloxy)-4-ethenyl-5,7-dihydroxy-4,10-dimethyl-8-oxo-15-oxatetracyclo[7.6.1.0¹,⁶.0¹³,¹⁶]hexadeca-6,9(16)-dien-10-yl]methyl 2-methylpropanoate
(1r,2s,3s,4ar,6ar,11as,11bs)-1,2-bis(acetyloxy)-4a-hydroxy-4,4,11b-trimethyl-7-methylidene-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-3-yl acetate
12β-hydroxyscillirosidin
{"Ingredient_id": "HBIN000760","Ingredient_name": "12\u03b2-hydroxyscillirosidin","Alias": "NA","Ingredient_formula": "C26H34O8","Ingredient_Smile": "CC(=O)OC1CC2(C(CC(C3(C2(CCC3C4=COC(=O)C=C4)O)C)O)C5(C1=CC(CC5)O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10692","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bersaldegenin-3-acetate
{"Ingredient_id": "HBIN017933","Ingredient_name": "bersaldegenin-3-acetate ","Alias": "NA","Ingredient_formula": "C26H34O8","Ingredient_Smile": "CC(=O)OC1CC(C2(C3CCC4(C(CCC4(C3CCC2(C1)O)O)C5=COC(=O)C=C5)C)C=O)O","Ingredient_weight": "474.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "21846","PubChem_id": "21768173","DrugBank_id": "NA"}